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presence of CAD based on angio or documented MI.. There were
11250 patients, we divided the cohort in to 2 Groups, namely, CAD
+ (Group 1) and CAD e (Group 2).
Results: Group-wise comparison showed the following Results:
Mean age in Group I significantly higher. (56.36 Vs 52.95) p z
0.0000. There were significantly higher number of males in Group
1. (6125 Vs 2682) p z 0.0000. DM (41.5%Vs 21.8%) p z 0.0000.
Smoking (13.1%Vs 5.7%) p z0.0000 were significantly higher in
Group 1. Mean HDL was significantly lower in Group 1. (39.42 Vs
41.75), p z 0.0000.
Stepwise logistic regression was done on 10,615 patients which
showed the following.
From the logistic regression analysis, adjusted for TC, TC/HDL,
HDL/LDL, HDL and HTN it is observed that:
CAD risk 3.037 times higher in males and 2.535 times higher in
DM, 2.107 times higher in smokers, 1.029 times higher with each
unit increase in Age. Not adjusting for Gender, analysis showed
CAD risk is 2.458 times higher in DM and 2.751 times higher in
smokers. Using Logistic regression model we found that in a 55
year old male, presence of diabetes increases the risk further by
18.82% and presence of smoking further increases by 9.15%.
Conclusion: 1) Traditional risk factors as age, DM, smoking have
significant association with CAD. 02) Average lipoprotein levels
were lower in our population.
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Background: There has been no Indian data on high dose statin in
our country.
Aims: To assess the tolerability and safety (A 80) in high risk
patients.
Methods: This is a retrospective observational study. 272
consecutive patients who were prescribed A80 and could be fol-
lowed for 2 years formed the cohort. Data were retrieved from
inpatient and outpatient records. Baseline demographics, initial
diagnosis, interventional procedure done, list of concomitant
medications, side effect profile, reason for dose reduction were all
obtained and analysed.
Results: There were 238 males (87.5%) & 34 females (12.5%) Mean
age was 56.4 year. HT was seen in 119 (43.75 %). DM in 109 (40.07%)
Dyslipidemia in 114 (41.9 %) Tobacco use in 75 (27.57%) 236 (86.7%)
patients presented with acute coronary syndrome. 204 (75 %)
STEMI; 17 (6.25%) NSTEMI and 14with unstable angina: (5.14%) 116
patients had 2VD on CAG. Mean TC 186, HDL 36.01, LDL 119, TG
143; Mean reduction in LDL was 49.3% in six months. 83 (30.51%)
patients had their dose reduction for various reasons. Maximal
reduction was seen in first six months, [(49/83). 62%]. 35 patients
had dose reduction due to financial reasons (43%). 29 patients had
dose reduction without any reason in the case file (34%). 15 pa-
tients had dose reduction due to side effects (18.07%). Cough was
seen in 4 (1.47%), Abdominal pain 2 (0.735%), Constipation in 3
(1.10%), Headache in 3 (1.10%) and Tiredness in 1, necessitating
dose reduction. One each had SGPT and CK elevation requiring
dose reduction. CK elevation more than 10 times was seen in one
patient requiring stopping the statin.
Conclusion: High dose statin therapy (A80) is safe, tolerable with
minimal side effects and should be prescribed to all deserving
patients similar to our study group.
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Background: Chronic total occlusion is defined as complete oc-
clusion of the coronary vessel with TIMI O flow, present for an
estimated duration of >3 months. Studies have found a frequency
of 15-20% of CTO in angiographies. Chronic total occlusion PCI has
experienced significant growth in the last few years with the
adaptation and refinement of advanced techniques.
Methods: Over the past 3 years, more than 250 CTO PTCA were
performed at ourcentre. We present an analysis of these CTO
PTCA done at our centre. Subjects were analysed with respect to
demographics, presentation, outcome and material used.
Results: Of the patients, males composed 72 % and females 28 % of
patients. The predominant presentation was chronic stable
angina (42%) followed by unstable angina (24%) and NSTEMI. The
average LV function was 45%, while viability of myocardium was
confirmed with stress thallium scans. The vessels involved were
LAD: 38%, RCA: 42%, and LCX: 20%. In 82% procedures, TIMI III flow
could be established without any complications. 12% procedures
were unsuccessful, primarily due to inability to cross the lesion.
Complications occured in 15 % of CTO PTCA. Of these, the com-
monest was: flap formation (7%). Perforation occured in 6% of
patients, of which 2 required placement of a covered stent, while
the others were managed by balloon occlusion. 2% patients
required pericardial tapping. Contrast induced nephropathy
occured in 1 patient, while 4 patients succumbed in the peri-
procedural period. 64% of the lesions were negotiated using reg-
ular angioplasty wires (our workhorse FIELDER FC PTCA wires),
while 36% required use of CTO wires.
Conclusion: CTO PTCA is one of the final frontiers of coronary
interventions, our experience shows that CTO PTCA shows
promising results, with complications rates that are progressively
diminishing. We would like to highlight that a majority CTO PTCA
were carried out using regular angioplasty wires with balloon
support as opposed to CTO wires.
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Background: Association of Red blood cell distribution width
(RDW) and coronary artery disease (CAD) is well established. But
other erythrocyte parameters Mean corpuscular volume (MCV),
Mean corpuscular Haemoglobin (MCH), Mean corpuscular hae-
moglobin concentration (MCHC) importance in pathogenesis of
CAD is not studied.
Methods: Retrospective analysis of 765 patients’ records (with
complete Haemogram), who underwent coronary angiogram for
suspected CAD in yearr 2013 at a tertiary care hospital were
included in this study. Patients were grouped into angiography
positive (AGP) (N¼438), angiography negative (AGN) (N¼327) based
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